P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
J. N. Nørgaard,
N. Abildgaard,
A. Lysén,
G. Tsykunova,
A. J. Vangsted,
C. Joao,
N. Remen,
L. Osnes,
J. P. Connelly,
M.-E. R. Revheim,
F. Schjesvold
Affiliations
J. N. Nørgaard
1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital
N. Abildgaard
4 Department of Hematology, Odense University Hospital
A. Lysén
1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital
G. Tsykunova
6 Division of Hematology, Haukeland University Hostpital, Bergen, Norway
A. J. Vangsted
7 Departmen of Hematology, Rigshospitalet, Copenhagen, Denmark
C. Joao
8 Department of Hematology, Champalimaud Centre for the Unknown, Lisboa, Portugal
N. Remen
1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital
L. Osnes
9 Department of Immunology
J. P. Connelly
10 Division for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway
M.-E. R. Revheim
2 Institute of Clinical Medicine
F. Schjesvold
1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital
